Blog

The 6th ISCAYAHL – International Symposium on Childhood, AYA Hodgkin Lymphoma

csihamburg-meeting.de

Jun 12, 2025, 08:39

The 6th ISCAYAHL – International Symposium on Childhood, AYA Hodgkin Lymphoma

The 6th ISCAYAHL – International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma will be held from October 15 to 18, 2025, at the Langenbeck-Virchow-Haus in Berlin, Germany. This event has established itself over the past 14 years as a vital forum for clinicians and researchers working in the field of Hodgkin lymphoma affecting younger populations.

The upcoming symposium will offer a comprehensive scientific agenda, focusing on key areas such as survivorship outcomes, global clinical trial initiatives, novel therapeutic biomarkers, cutting-edge developments in lymphoma biology, and advanced imaging technologies. The program will also highlight the role of international collaborations in driving innovation and improving standards of care.

A special feature of the event will be the Hodgkin Lymphoma Survivor Panel Discussion. This panel will provide former patients a platform to share their experiences and perspectives with the scientific community.

Organized in collaboration with a Scientific Committee, the symposium will include ten main session topics, all open for abstract submissions. The event will also mark the 4th presentation of the Günther-Schellong Prize, recognizing outstanding contributions to the field. The symposium will conclude with an Abstract Award Session, celebrating impactful research in Hodgkin lymphoma.

With its return to the historic Charité University Medical Center venue, the 6th ISCAYAHL underscores its commitment to fostering international partnerships and promoting sustained improvements in outcomes and quality of life for children, adolescents, and young adults diagnosed with Hodgkin lymphoma.

Symposium information

Symposium website.
Dates: October 15-18, 2025
Location: Langenbeck-Virchow-Haus, Berlin
Symposium target audience: Scientists and clinicians involved in the research and treatment of Hodgkin lymphoma in children, adolescents, and young adults.
Focus areas: Survivorship outcomes, global clinical trial portfolios, novel therapeutic biomarkers, advances in lymphoma biology, and innovative imaging techniques.